Nautilus Biotechnology CEO Sujal Patel had to deliver tough news on a Thursday morning call with analysts. The company has ...

SELLAS Life Sciences CEO Angelos Stergiou says his company is already on the cusp of a finalized leukemia vaccine, but another game-changer – personalized cancer vaccines – could be on the ...

Yvonne Greenstreet, CEO of Alnylam, talked about the opportunities unlocked by genomics in an interview with Barron's Andy Serwer.